Sentence examples for ip factors from inspiring English sources

The four IP factors were chosen as they were representative profiles containing broad peaks (CBP and H3K27Me3) and narrow peaks (H3K4Me1 and H3K4Me3).

However, to date there is a lack of systematic comparison between ChIP-chip and ChIP-seq based on a large dataset from multiple IP factors.

In this study, we compiled and analyzed 31 pairs of ChIP-chip/ChIP-seq profiles of technical replicates across eight immunoprecipitation (IP) factors (CBP, RNA PolII, and six histone modifications) at four developmental stages of the common fruit fly Drosophila melanogaster (Table 1) as part of the model organism Encyclopedia of DNA Elements (modENCODE) project [ 27].

However, the intra-platform concordance can be as low as the inter-platform concordance when analyzing the profiles of H3K27Me3 and CBP, implying that variation in peak calling algorithms can be as large as the use of different profiling technologies for some IP factors.

We only had access to four ChIP-seq/ChIP-seq replicate profiles across two IP factors (CBP and CTCF) in this study, so the estimate of intra-platform reproducibility of ChIP-seq may be less accurate than that of ChIP-chip.

The associations of baseline NT-pro-BNP with IP related factors and CVD were assessed by linear regression.

The association between NT-pro-BNP and CVD mortality was no longer significant in the model (model D) that included both CVD and IP related factors (HR (95% CI) 2.18 (0.76 to 6.27)) (table 3).

Such studies were available for the following polymorphism – IP pairs: factor V Leiden - activated protein C resistance, ACE D/I - ACE activity, MTHFR - homocysteine levels, prothrombin G20210A - prothrombin levels, and PAI-1 4G/5G - PAI-1 levels.

Ip: the factor by which the risk is multiplied when the child receives a risk allele from the father (Ainsworth et al. 2011; Weinberg et al. 1998).

In the 1990s and early 2000s, it was often asserted that patents and other forms of IP were major factors limiting access by the poor to new health technologies.

In addition to contributing to a better understanding of the aetiology of IP, such lifestyle factors may also help to stratify subjects in the general population according to their level of risk of IP for further genetic and serological testing, with the aim of preventing the development of IP.